Accuramed Biotechnology Limited

AccuraMed Biotechnology Limited (also operating under the name 云准医药科技（上海）有限公司) was founded in 2016. It is a high-tech company focusing on the detection and analysis of tissue biological markers, the discovery of innovative drugs, and the development of new diagnostic technologies. They provide innovative solutions for tumor drug target research and advanced immunodiagnostic testing. AccuraMed is dedicated to advancing tumor immune research and supports clinical and basic research by providing advanced analysis of the tumor immune microenvironment. The company collaborates with research institutions, universities, hospitals, and biotechnology companies. They also offer the Acculib-Mate24, a fully automated library construction system developed in partnership with Hamilton, designed to streamline single-cell library construction, support high-throughput, and reduce errors.